| 000 | 01790 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516141725.0 | ||
| 264 | 0 | _c20140429 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1468-2060 | ||
| 024 | 7 |
_a10.1136/annrheumdis-2012-202848 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMirjafari, Hoda | |
| 245 | 0 | 0 |
_aN-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR). _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cApr 2014 |
||
| 300 |
_a684-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aArthritis _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xblood |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aEngland _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNatriuretic Peptide, Brain _xblood |
| 650 | 0 | 4 |
_aPeptide Fragments _xblood |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 700 | 1 | _aWelsh, Paul | |
| 700 | 1 | _aVerstappen, Suzanne M M | |
| 700 | 1 | _aWilson, Paddy | |
| 700 | 1 | _aMarshall, Tarnya | |
| 700 | 1 | _aEdlin, Helena | |
| 700 | 1 | _aBunn, Diane | |
| 700 | 1 | _aChipping, Jacqueline | |
| 700 | 1 | _aLunt, Mark | |
| 700 | 1 | _aSymmons, Deborah P M | |
| 700 | 1 | _aSattar, Naveed | |
| 700 | 1 | _aBruce, Ian N | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 73 _gno. 4 _gp. 684-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/annrheumdis-2012-202848 _zAvailable from publisher's website |
| 999 |
_c22597846 _d22597846 |
||